Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

bispecific monoclonal antibody ASP2074

A bispecific monoclonal antibody directed against as of yet unknown targets, with potential antineoplastic activity. Upon administration, bispecific monoclonal antibody ASP2074 may, through as of yet unelucidated mechanisms of action, enhance cellular immune responses against susceptible tumor cells, resulting in increased tumor cell lysis.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:bispecific antibody ASP2074
Code name:ASP 2074
ASP-2074
ASP2074
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search